Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 August, 2018 01:56 IST
Dr. Reddy's Lab gets first-cycle approval for Impoyz cream
Source: IRIS | 01 Dec, 2017, 11.42AM
Comments  |  Post Comment

Dr. Reddy's Laboratories, through its wholly owned subsidiary Promius Pharma, LLC, has received fifth consecutive, first-cycle NDA approval for the Proprietary Products Group, a substantial milestone within the pharmaceutical industry.

Impoyz (clobetasol propionate) Cream, 0.025% is a high potency topical steroid approved for the treatment of moderate to severe plaque psoriasis in patients 18 years of age or older. The most common side effect of IMPOYZ Cream includes discoloration of the treated site. Psoriasis is a serious medical condition affecting approximately 7.5 million people in the United States. Impoyz, formerly referred to as DFD-06, had been recently licensed to Encore Dermatology Inc. for the commercialization of the product in the United States.

This approval is another example of the deep and broad capabilities within the Proprietary Products business unit at Dr. Reddy's. (Q,N,C,F)* The organization has achieved several milestones within drug, device, and formulation research and development for novel therapies.

Shares of the company declined Rs 11.35, or 0.5%, to trade at Rs 2,275.00. The total volume of shares traded was 12,848 at the BSE (11.27 a.m., Friday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Ion Exchange secures EPC contract worth Rs 4.38 bn - 17-Aug-2018 11:35
IL&FS Transportation Networks to receive Rs 430 mn from Ramky Infra - 17-Aug-2018 11:32
IL&FS Transportation Networks to receive Rs 430 mn from Ramky Infra - 17-Aug-2018 11:32
Ashok Leyland wins overseas order for 300 double decker buses - 17-Aug-2018 09:51
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
NBCC secures work order worth Rs 2.50 bn from SAIL - 16-Aug-2018 15:35
MCX inks MoU with Indian Bullion and Jewellers Association - 16-Aug-2018 15:31
Alfa Transformers bags order worth Rs 171.1 mn from Uttar Gujarat Vij Co - 16-Aug-2018 12:25
TVS Motor Co bets big on Philippines with new product launches - 16-Aug-2018 09:54
Sun Pharma gets USFDA approval for Cequa ophthalmic solution - 16-Aug-2018 09:33
TCS named leader in KYC-AML BPO services by Everest Group - 14-Aug-2018 12:04
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer